Xiaomo’s story

Xiaomo focuses on developing cutting-edge products based on the RNA interference (RNAi) technology. RNAi uses small interfering RNA (siRNA) molecules to precisely suppress genes in the cells. Xiaomo owns a unique platform technology of RNAi and is developing first-in-class siRNA products, including for example RNAi pesticide, to address huge unmet needs in agriculture and gene therapy.

Xiaomo is a proud member of Hong Kong’s flagship biotech incubator – Incu-Bio at Hong Kong Science Park.